Patrick Hlavacek

923 total citations
64 papers, 609 citations indexed

About

Patrick Hlavacek is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Patrick Hlavacek has authored 64 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 23 papers in Internal Medicine and 21 papers in Hematology. Recurrent topics in Patrick Hlavacek's work include Atrial Fibrillation Management and Outcomes (26 papers), Venous Thromboembolism Diagnosis and Management (23 papers) and Multiple Myeloma Research and Treatments (20 papers). Patrick Hlavacek is often cited by papers focused on Atrial Fibrillation Management and Outcomes (26 papers), Venous Thromboembolism Diagnosis and Management (23 papers) and Multiple Myeloma Research and Treatments (20 papers). Patrick Hlavacek collaborates with scholars based in United States, United Kingdom and Sweden. Patrick Hlavacek's co-authors include Joseph C. Cappelleri, Alesia Sadosky, Marco DiBonaventura, Bruce Parsons, Ian Kudel, Markay Hopps, Lisa Rosenblatt, Allison Keshishian, Hüseyin Yüce and A. Alexander and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Patrick Hlavacek

53 papers receiving 600 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Patrick Hlavacek 189 163 151 107 99 64 609
Paweł Kuca 347 1.8× 135 0.8× 146 1.0× 16 0.1× 99 1.0× 35 915
Julia Otten 109 0.6× 310 1.9× 117 0.8× 24 0.2× 138 1.4× 34 703
Michael Nowitz 50 0.3× 350 2.1× 135 0.9× 157 1.5× 72 0.7× 13 830
Siyan Chen 69 0.4× 52 0.3× 38 0.3× 33 0.3× 74 0.7× 32 730
Luis Enrique Colunga‐Lozano 60 0.3× 28 0.2× 77 0.5× 12 0.1× 49 0.5× 28 540
Thomas Bo Jensen 166 0.9× 27 0.2× 65 0.4× 48 0.4× 62 0.6× 40 603
Yan Liang 294 1.6× 49 0.3× 32 0.2× 10 0.1× 102 1.0× 53 569
Mehrtash Hashemzadeh 661 3.5× 70 0.4× 81 0.5× 14 0.1× 166 1.7× 67 1.1k
Dylan M. Zylla 62 0.3× 46 0.3× 94 0.6× 184 1.7× 67 0.7× 34 806
Ayeesha Kamran Kamal 195 1.0× 30 0.2× 116 0.8× 7 0.1× 218 2.2× 42 741

Countries citing papers authored by Patrick Hlavacek

Since Specialization
Citations

This map shows the geographic impact of Patrick Hlavacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hlavacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hlavacek more than expected).

Fields of papers citing papers by Patrick Hlavacek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Hlavacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hlavacek. The network helps show where Patrick Hlavacek may publish in the future.

Co-authorship network of co-authors of Patrick Hlavacek

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Hlavacek. A scholar is included among the top collaborators of Patrick Hlavacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Hlavacek. Patrick Hlavacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Bhavesh, Rickard Sandin, Yun Liu, et al.. (2025). Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma. ClinicoEconomics and Outcomes Research. Volume 17. 289–302.
2.
LeBlanc, Thomas W., et al.. (2025). Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison. Journal of Comparative Effectiveness Research. 14(5). e240236–e240236. 1 indexed citations
3.
Costa, Luciano J., Thomas W. LeBlanc, Hans Tesch, et al.. (2024). Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future Oncology. 20(17). 1175–1189. 6 indexed citations
4.
5.
6.
7.
8.
9.
10.
Charalampous, Charalampos, Shaji Kumar, Ricardo Parrondo, et al.. (2023). Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study. Blood. 142(Supplement 1). 6727–6727.
11.
12.
Turakhia, Mintu P., Jennifer D. Guo, Allison Keshishian, et al.. (2023). Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States. Clinical Cardiology. 46(5). 484–493. 19 indexed citations
13.
Munir, Muhammad Bilal, Patrick Hlavacek, Allison Keshishian, et al.. (2022). Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database. PLoS ONE. 17(2). e0263903–e0263903. 3 indexed citations
14.
Hlavacek, Patrick, Allison Keshishian, Jennifer D. Guo, et al.. (2021). UNDERUTILIZATION OF ORAL ANTICOAGULANT THERAPY AMONG ELDERLY PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE UNITED STATES MEDICARE DATABASE. Journal of the American College of Cardiology. 77(18). 1641–1641. 1 indexed citations
15.
Turakhia, Mintu P., Jennifer D. Guo, Allison Keshishian, et al.. (2021). CONTEMPORARY PREVALENCE ESTIMATES OF UNDIAGNOSED AND DIAGNOSED ATRIAL FIBRILLATION IN THE UNITED STATES. Journal of the American College of Cardiology. 77(18). 1499–1499.
16.
Kuchta, Kristine, Andres Quintero, Patrick Hlavacek, et al.. (2020). National Physician Survey for Nonvalvular Atrial Fibrillation (NVAF) Anticoagulation Comparing Knowledge, Attitudes and Practice of Cardiologist to PCPs. Clinical and Applied Thrombosis/Hemostasis. 26. 2874351078–2874351078. 6 indexed citations
17.
Yu, Shengyuan, Bifa Fan, Fei Yang, et al.. (2019). <p>Patient and economic burdens of postherpetic neuralgia in China</p>. ClinicoEconomics and Outcomes Research. Volume 11. 539–550. 25 indexed citations
18.
Kudel, Ian, Markay Hopps, Joseph C. Cappelleri, et al.. (2019). Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam. Journal of Pain Research. Volume 12. 255–268. 10 indexed citations
19.
Udall, Margarita, Ian Kudel, J.C. Cappelleri, et al.. (2017). Epidemiology of Physician-Diagnosed Neuropathic Pain in Brazil. Value in Health. 20(9). A902–A903. 3 indexed citations
20.
Cappelleri, Joseph C., et al.. (2016). MAPPING THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES ARTHRITIS INDEX (WOMAC) TO THE EQ-5D. Value in Health. 19(3). A235–A236. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paweł Kuca Breakdown of academic impact, for papers by Julia Otten Breakdown of academic impact, for papers by Michael Nowitz Breakdown of academic impact, for papers by Siyan Chen Breakdown of academic impact, for papers by Luis Enrique Colunga‐Lozano Breakdown of academic impact, for papers by Thomas Bo Jensen Breakdown of academic impact, for papers by Yan Liang Breakdown of academic impact, for papers by Mehrtash Hashemzadeh Breakdown of academic impact, for papers by Dylan M. Zylla Breakdown of academic impact, for papers by Ayeesha Kamran Kamal
Rankless by CCL
2026